SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-16-041751
Filing Date
2016-11-10
Accepted
2016-11-10 16:07:06
Documents
53
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q kmph20161012_10q.htm 10-Q 1242614
2 EXHIBIT 10.3 ex10-3.htm EX-10.3 47266
3 EXHIBIT 31.1 ex31-1.htm EX-31.1 14835
4 EXHIBIT 31.2 ex31-2.htm EX-31.2 14959
5 EXHIBIT 32.1 ex32-1.htm EX-32.1 6326
6 EXHIBIT 32.2 ex32-2.htm EX-32.2 6451
  Complete submission text file 0001437749-16-041751.txt   4154286

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT kmph-20160930.xml EX-101.INS 583794
8 XBRL TAXONOMY EXTENSION SCHEMA kmph-20160930.xsd EX-101.SCH 38924
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kmph-20160930_cal.xml EX-101.CAL 31881
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kmph-20160930_def.xml EX-101.DEF 328034
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE kmph-20160930_lab.xml EX-101.LAB 239072
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kmph-20160930_pre.xml EX-101.PRE 331973
Mailing Address 2500 CROSSPARK ROAD, SUITE E126 CORALVILLE IA 52241
Business Address 2500 CROSSPARK ROAD, SUITE E126 CORALVILLE IA 52241 319-665-2575
KEMPHARM, INC (Filer) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36913 | Film No.: 161988082
SIC: 2834 Pharmaceutical Preparations